Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Jones Website

Kathryn S. Jones, Ph.D.

Selected Publications

1)  Jones KS, Lambert S, Bouttier M, Bénit L, Ruscetti FW, Hermine O, Pique C.
Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
Viruses. 3: 794-810, 2011.
[Journal]
2)  Jones KS, Green PL.
Cloaked virus slips between cells.
Nat. Med. 16: 25-27, 2010.
[Journal]
3)  Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O.
Current concepts regarding the HTLV-1 receptor complex.
Retrovirology. 7: 99, 2010.
[Journal]
4)  Van Prooyen N, Gold H, Andresen V, Schwartz O, Jones K, Ruscetti F, Lockett S, Gudla P, Venzon D, Franchini G.
Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission.
Proc. Natl. Acad. Sci. U.S.A. 107: 20738-43, 2010.
[Journal]
5)  Ilinskaya A, Heidecker G, Jones K.
Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.
Future Med Chem. 2: 1651-68, 2010.
[Journal]
6)  Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G.
Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.
J. Virol. 84: 3043-58, 2010.
[Journal]
7)  Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, Chung HK, Fukumoto R, Parks RW, Ferrari MG, Nicot C, Cecchinato V, Ruscetti F, Franchini G.
Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.
Blood. 116: 3809-17, 2010.
[Journal]
8)  Lee K, Jones KS.
The path well traveled: using mammalian retroviruses to guide research on XMRV.
Mol. Interv. 10: 20-4, 2010.
[Journal]
9)  Lambert S, Bouttier M, Vassy R, Seigneuret M, Petrow-Sadowski C, Janvier S, Heveker N, Ruscetti FW, Perret G, Jones KS, Pique C.
HTLV-1 uses HSPG and neuropilin 1 for entry by molecular mimicry of VEGF165.
Blood. 2009.
[Journal]
10)  Jones KS, Huang YK, Chevalier SA, Afonso PV, Petrow-Sadowski C, Bertolette DC, Gessain A, Ruscetti FW, Mahieux R.
The receptor complex associated with HTLV-3 Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
J. Virol. 2009.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 9/21/2012.